BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32507966)

  • 1. The extent of surgery for low-risk 1-4 cm papillary thyroid carcinoma: a catch-22 situation. A retrospective analysis of 497 patients based on the 2015 ATA Guidelines recommendation 35.
    Anda Apiñániz E; Zafon C; Ruiz Rey I; Perdomo C; Pineda J; Alcalde J; García Goñi M; Galofré JC
    Endocrine; 2020 Dec; 70(3):538-543. PubMed ID: 32507966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobectomy Compared to Total Thyroidectomy for Low-Risk Papillary Thyroid Cancer: A Systematic Review.
    Vargas-Pinto S; Romero Arenas MA
    J Surg Res; 2019 Oct; 242():244-251. PubMed ID: 31103828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: A meta-analysis.
    Macedo FI; Mittal VK
    Surg Oncol; 2015 Jun; 24(2):117-22. PubMed ID: 25956302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
    Liu J; Zhang Z; Huang H; Xu S; Liu Y; Liu S; Wang X; Xu Z
    Oral Oncol; 2019 Mar; 90():17-22. PubMed ID: 30846171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
    World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study.
    Kuba S; Yamanouchi K; Hayashida N; Maeda S; Adachi T; Sakimura C; Kawakami F; Yano H; Matsumoto M; Otsubo R; Sato S; Fujioka H; Kuroki T; Nagayasu T; Eguchi S
    Int J Surg; 2017 Feb; 38():143-148. PubMed ID: 27677707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid Lobectomy for Low-Risk 1-4 CM Papillary Thyroid Cancer is not Associated with Increased Recurrence Rates in the Dutch Population with a Restricted Diagnostic Work-Up.
    Lin JF; Rodriguez Schaap PM; Metman MJH; Nieveen van Dijkum EJM; Dickhoff C; Links TP; Kruijff S; Engelsman AF
    World J Surg; 2023 May; 47(5):1211-1218. PubMed ID: 36303039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urban and Rural Surgical Practice Patterns for Papillary Thyroid Carcinoma.
    Collins RA; Chaves N; Lee G; Broekhuis JM; James BC
    Thyroid; 2023 Jul; 33(7):849-857. PubMed ID: 37014086
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulating the extension of thyroidectomy in patients with papillary thyroid carcinoma pre-operatively eligible for lobectomy: reliability of ipsilateral central neck dissection.
    Raffaelli M; De Crea C; Sessa L; Tempera SE; Fadda G; Pontecorvi A; Bellantone R
    Endocrine; 2021 May; 72(2):437-444. PubMed ID: 32820358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Thyroidectomy vs Thyroid Lobectomy for Localized Papillary Thyroid Cancer in Children: A Propensity-Matched Survival Analysis.
    Memeh K; Ruhle B; Alsafran S; Vaghaiwalla T; Kaplan E; Angelos P; Keutgen XM
    J Am Coll Surg; 2021 Jul; 233(1):39-49. PubMed ID: 33887483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy.
    DiMarco AN; Wong MS; Jayasekara J; Cole-Clark D; Aniss A; Glover AR; Delbridge LW; Sywak MS; Sidhu SB
    BJS Open; 2019 Jun; 3(3):299-304. PubMed ID: 31183445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma.
    Feng JW; Ye J; Wu WX; Pan H; Qin AC; Jiang Y; Wu BQ
    Front Endocrinol (Lausanne); 2020; 11():553577. PubMed ID: 33133013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis.
    Wrenn SM; Wang TS; Toumi A; Kiernan CM; Solórzano CC; Stephen AE
    Am J Surg; 2021 Feb; 221(2):448-454. PubMed ID: 32933747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperatively determined high-risk histopathologic features in papillary thyroid carcinoma initially eligible for thyroid lobectomy: a game changer.
    Bakkar S; Al-Omar K; Donatini G; Aljarrah Q; Papavramidis TS; Materazzi G; Miccoli P
    Endocrine; 2021 Dec; 74(3):611-615. PubMed ID: 34110601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
    Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
    Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features.
    Suman P; Razdan SN; Wang CE; Tulchinsky M; Ahmed L; Prinz RA; Winchester DJ
    J Am Coll Surg; 2020 Jan; 230(1):136-144. PubMed ID: 31672668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
    Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
    J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes After Lobectomy for Patients with High-Risk Papillary Thyroid Carcinoma.
    Sugitani I; Kazusaka H; Ebina A; Shimbashi W; Toda K; Takeuchi K
    World J Surg; 2023 Feb; 47(2):382-391. PubMed ID: 35972533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.